Human papillomavirus vaccine uptake among 18‐ to 26‐year‐old women in the United States

Abstract

Background HPV vaccine uptake among young adult women has been reported to be very low. We conducted this study to provide an update on HPV vaccine uptake among 18–26 year old women. Methods We used the National Health Interview Survey 2010 data to estimate HPV vaccine coverage and their correlates. Results Overall, 22.7% of women initiated (≥1 dose) and 12.7% completed the vaccine (≥3 doses). Thus, about 56% of women who initiated the vaccine completed it. Multivariate logistic regression analyses showed that younger age, unmarried status, Pap test, influenza vaccine, lifetime vaccines, and HPV vaccine awareness were positively associated with receiving ≥1 and ≥3 doses. In addition, uninsured women were less likely to receive ≥1 dose (odds ratio (OR) 0.49, 95% confidence intervals (CI) 0.28–0.84), blacks (OR 0.48, 95% CI 0.23–0.99) and women with a family income <100% of the federal poverty line (OR 0.40, 95% CI 0.21–0.73) were less likely to receive ≥3 doses. Further, based on vaccine initiators, blacks were less likely than whites to complete the vaccine (OR 0.29, 95% CI 0.16–0.55). Two-thirds of unvaccinated women were not interested in future vaccination. Among those who were interested, more than 76.4% preferred to receive it free or at a lower cost while 20% would pay the full cost of the vaccine. Conclusion One in 8 women completed the 3-dose HPV vaccine. Educational and vaccine financing programs are needed to improve the uptake among low-income minority women who are at increased risk for cervical cancer.

How Might Immunization Rates Change if Cost Sharing is Eliminated?

“…[31][32][33] However, the use of HPV vaccine among adolescent girls has not yet experienced the same success. 34,35 Identifying effective strategies to extend the reach of these new types of vaccines, especially as they touch on sensitive issues such as child sexuality, are essential. Annual well-child visits are the foundation for the adolescent immunization platform; however, additional visits required to complete the necessary number of doses to be fully immunized are a logistical challenge in addressing this population.…”

“…First, we used the 2008 National Immunization Survey (NIS) for children aged [19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35] We based our analyses on nearly 3.5 million members who were enrolled in plans that could be identified. The plan identifiers allowed us to determine the costsharing characteristics of each plan and calculate the immunization rates at the plan level.…”

Identification of potential missed opportunities for human papillomavirus (HPV) vaccination in women referred to an academic colposcopy clinic for evaluation of abnormal cervical cytology

“…10,15,16 One significant negative predictor is older age between 18-26 where completion of the 3 dose HPV vaccine declines significantly from 21.6% at ages 18-20 to 9.5% at ages [21][22][23][24][25][26]. 17 The objective of this study is to identify characteristics of patients referred to an academic colposcopy clinic who may have had missed CONTACT Benjamin J. Dorton bdorts9@gmail.com opportunities for HPV counseling and vaccination prior to presenting with abnormal cytology or HPV screening tests.…”

HPV vaccine uptake after introduction of the vaccine in Germany

“…14,15 In fact, an overview of the HPV vaccination coverage in Europe has shown results ranging from 17% to 81% in the first 2 y after introduction of the vaccine in the respective countries, with the lowest rates in France, Luxemburg, and Norway and the highest in Portugal and the United Kingdom. 15 In the United States, the reported proportion of girls in the age group of 13-17 y who had received at least one vaccine dose ranged from 34.8% 16 in the National Health Interview Survey (NHIS) to 48.7% 17 and 53.8% 18 in the National Immunization Survey-Teen (NIS-Teen) in 2010 and 2012, respectively. In Australia, where a school-based vaccination program has been implemented, the proportion of girls in the seventh grade (~12 y of age) receiving the vaccination has been shown to be about 80% in 2009, 2010, and 2011.…”